Mississippi's Point out Board of Health care Licensure now prohibits prescribing, dispensing, or administrating compounded semaglutide for weight loss, citing security issues, but guidelines vary from point out to state. Clients can seek the advice of the FDA's BeSafeRx campaign to navigate